#ThinkSabio Latest News
BioCardia Announces Positive DSMB Review of CardiALLO Allogeneic Cell Therapy for Heart Failure Phase 1/2 Clinical Trial
BioCardia, Inc. (BCDA) Stock Price, Latest News, Company Profile & Institutional Holding
LightDark
BioCardia Announces Positive DSMB Review of CardiALLO Allogeneic Cell Therapy for Heart Failure Phase 1/2 Clinical Trial